Skip to main content

Table 1 Laboratory findings upon admission (on day 44)

From: Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report

Blood test

Urine test

 White blood cell

3800/μL

C-reactive protein

0.09 mg/dL

 Gravity

1.023

 Neutrophil

57.6%

IgG

590 mg/dL

 pH

6.0

 Lymphocyte

29.3%

IgA

125 mg/dL

 Protein

4+

 Hemoglobin

11.3 g/dL

IgM

72 mg/dL

 Occult blood

3+

 Hematocrit

33.7%

Complement 3

109 mg/dL

 White blood cell

0 /HPF

 Platelet

57,000/μL

Complement 4

18.8 mg/dL

 Red blood cell

10–19 /HPF

 Total protein

5.7 g/dL

CH50

47 IU/mL

 Dysmorphic erythrocyte

+

 Albumin

3.0 g/dL

Hepatitis B s antigen

–

 Protein

941 mg/dL

 Blood urea nitrogen

19 mg/dL

Hepatitis C virus antibody

–

 Creatinine

184 mg/dL

 Creatinine

0.65 mg/dL

    
  1. HPF high power field